AHEAD Intelligence(先勁智能)著重於利用機器學習開發快速、精準與客觀細胞檢測資料分析平台協助加速用於疫苗、藥物研發、細胞治療、疾病診斷與追蹤所需要的檢測資料分析 AHEAD創辦人團隊集結來自台大醫院內科部血液科、台大醫學院內科、清大電機工程學系人類行為訊息暨互動計算研究室等專家,目前積極拓展國際市場 AHEAD delivers on-demand insights by replacing human visual interpretation of cell-level data with AI and machine learning. As the software intelligence layer between machine generated cell-level details and humans, the AHEAD platform offers AI/ML enhanced accuracy, 10X-20X faster results, and 3-6X lower costs. Low cost, on-demand insights, and higher productivity enable AHEAD to relieve bottlenecks and enable global availability.